Abstract
Background:
Measuring messenger RNA (mRNA) levels using the reverse transcription quantitative polymerase chain reaction (RT-qPCR) is common practice in many laboratories. A specific set of mRNAs as internal control reference genes is considered as the preferred strategy to normalize RT-qPCR data. Proper selection of reference genes is a critical issue, especially in cancer cells that are subjected to different in vitro manipulations. These manipulations may result in dramatic alterations in gene expression levels, even of assumed reference genes. In this study, we evaluated the expression levels of 11 commonly used reference genes as internal controls for normalization of 19 experiments that include neuroblastoma, T-ALL, melanoma, breast cancer, non small cell lung cancer (NSCL), acute myeloid leukemia (AML), prostate cancer, colorectal cancer, and cervical cancer cell lines subjected to various perturbations.
Results:
The geNorm algorithm in the software package qbase+ was used to rank the candidate reference genes according to their expression stability. We observed that the stability of most of the candidate reference genes varies greatly in perturbation experiments. Expressed Alu repeats show relatively stable expression regardless of experimental condition. These Alu repeats are ranked among the best reference assays in all perturbation experiments and display acceptable average expression stability values (M<0.5).
Conclusions:
We propose the use of Alu repeats as a reference assay when performing cancer cell perturbation experiments.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alu Elements*
-
Angiogenesis Inhibitors / pharmacology
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism
-
Cell Line, Tumor
-
Conserved Sequence
-
Gene Expression Profiling / standards*
-
Gene Knockdown Techniques
-
Humans
-
MicroRNAs / genetics
-
Protein Kinase Inhibitors / pharmacology
-
Pyrimidines / pharmacology
-
RNA, Small Interfering / genetics
-
Real-Time Polymerase Chain Reaction / standards*
-
Reference Standards
-
Repressor Proteins
-
Reverse Transcriptase Polymerase Chain Reaction / standards*
-
Transcriptome / drug effects
-
Tretinoin / pharmacology
-
Withanolides / pharmacology
Substances
-
Angiogenesis Inhibitors
-
Carrier Proteins
-
MicroRNAs
-
NVP-TAE684
-
PHF6 protein, human
-
Protein Kinase Inhibitors
-
Pyrimidines
-
RNA, Small Interfering
-
Repressor Proteins
-
Withanolides
-
Tretinoin
-
withaferin A
Grants and funding
Ali Rihani is supported by a PhD fellowship from the Ghent University research fund (BOF; 01D02210). Joni Van der Meulen and Evelien Mets are supported by a PhD fellowship from the Research Foundation – Flanders (FWO; 1116412N and 3G020209, respectively). Anneleen Beckers is supported by a PhD fellowship from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT; 101506). Tom Van Maerken, Pieter Mestdagh and Pieter Rondou are supported by postdoctoral fellowships from the FWO. SDB is supported by a postdoctoral fellowship from Ghent University (GOA UGENT; 01G01910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.